19/06/2026
What if the next breakthrough in KRAS drug discovery is already hidden in a patent?
As KRAS-related patents continue to grow, extracting and structuring high-quality SAR data has become a major challenge for researchers.
Our case study shows how patent-derived SAR data from GOSTAR™ provided access to 16,444 KRAS compounds, 24× more than ChEMBL, while reducing data collection and curation efforts by 60–70%.
Read the full case study to learn more: https://na2.hubs.ly/H06cpbx0